Pfizer Contemplates $2 Billion Acquisition of Strides’ Agila Unit

News   Jan 17, 2013

 
Pfizer Contemplates $2 Billion Acquisition of Strides’ Agila Unit
 
 
 
 

RELATED ARTICLES

Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

News

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

READ MORE

NIH links Aldosterone to Alcohol Use Disorder

News

National Institutes of Health study demonstrates that aldosterone, a hormone produced in the adrenal glands, may contribute to alcohol use disorder (AUD)

READ MORE

Big-Data Analysis Points Toward New Drug Discovery Method

News

A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE